Home > News > Disease diagnosis, drug development focus of UH prof's biochip research
September 1st, 2004
Disease diagnosis, drug development focus of UH prof's biochip research
Abstract:
Leading the way to disease diagnosis and drug development, biochip research at the University of Houston will be presented to an international audience of top nanoscientists next week. B. Montgomery Pettitt, the Hugh Roy and Lillie Cranz Cullen Distinguished Professor of Chemistry at the University of Houston, has been selected as one of the plenary speakers at the Pacific Rim Nanoscience Conference Sept. 7-11 in Broome, Western Australia. Pettitt is one of only three American scientists among the 21 invited speakers.
Source:
medicalnewstoday
Bookmark:
| Related News Press |
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||